Imaging Alzheimer's amyloid

被引:87
作者
Selkoe, DJ [1 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA
关键词
D O I
10.1038/78422
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:823 / 824
页数:2
相关论文
共 12 条
[1]   99mTc-MAMA-chrysamine G, a probe for beta-amyloid protein of Alzheimer's disease [J].
Dezutter, NA ;
Dom, RJ ;
de Groot, TJ ;
Bormans, GM ;
Verbruggen, AM .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (11) :1392-1399
[2]   Transition-state analogue inhibitors of γ-secretase bind directly to presenilin-1 [J].
Esler, WP ;
Kimberly, WT ;
Ostaszewski, BL ;
Diehl, TS ;
Moore, CL ;
Tsai, JY ;
Rahmati, T ;
Xia, WM ;
Selkoe, DJ ;
Wolfe, MS .
NATURE CELL BIOLOGY, 2000, 2 (07) :428-434
[3]   High cerebrospinal fluid tau and low amyloid β42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype [J].
Galasko, D ;
Chang, L ;
Motter, R ;
Clark, CM ;
Kaye, J ;
Knopman, D ;
Thomas, R ;
Kholodenko, D ;
Schenk, D ;
Lieberburg, I ;
Miller, B ;
Green, R ;
Basherad, R ;
Kertiles, L ;
Boss, MA ;
Seubert, P .
ARCHIVES OF NEUROLOGY, 1998, 55 (07) :937-945
[4]   Longitudinal study of cerebrospinal fluid levels of tau, Aβ1-40, and Aβ1-42(43) in Alzheimer's disease:: A study in Japan [J].
Kanai, M ;
Matsubara, E ;
Isoe, K ;
Urakami, K ;
Nakashima, K ;
Arai, H ;
Sasaki, H ;
Abe, K ;
Iwatsubo, T ;
Kosaka, T ;
Watanabe, M ;
Tomidokoro, Y ;
Shizuka, M ;
Mizushima, K ;
Nakamura, T ;
Igeta, Y ;
Ikeda, Y ;
Amari, M ;
Kawarabayashi, T ;
Ishiguro, K ;
Harigaya, Y ;
Wakabayashi, K ;
Okamoto, K ;
Hirai, S ;
Shoji, M .
ANNALS OF NEUROLOGY, 1998, 44 (01) :17-26
[5]   CHRYSAMINE-G BINDING TO ALZHEIMER AND CONTROL BRAIN - AUTOPSY STUDY OF A NEW AMYLOID PROBE [J].
KLUNK, WE ;
DEBNATH, ML ;
PETTEGREW, JW .
NEUROBIOLOGY OF AGING, 1995, 16 (04) :541-548
[6]   Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1 [J].
Li, YM ;
Xu, M ;
Lai, MT ;
Huang, Q ;
Castro, JL ;
DiMuzio-Mower, J ;
Harrison, T ;
Lellis, C ;
Nadin, JL ;
Neduvelil, JG ;
Register, RB ;
Sardana, MK ;
Shearman, MS ;
Smith, AL ;
Shi, XP ;
Yin, KC ;
Shafer, JA ;
Gardell, SJ .
NATURE, 2000, 405 (6787) :689-694
[7]   REVERSIBLE INVITRO GROWTH OF ALZHEIMER-DISEASE BETA-AMYLOID PLAQUES BY DEPOSITION OF LABELED AMYLOID PEPTIDE [J].
MAGGIO, JE ;
STIMSON, ER ;
GHILARDI, JR ;
ALLEN, CJ ;
DAHL, CE ;
WHITCOMB, DC ;
VIGNA, SR ;
VINTERS, HV ;
LABENSKI, ME ;
MANTYH, PW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (12) :5462-5466
[8]   REDUCTION OF BETA-AMYLOID PEPTIDE(42), IN THE CEREBROSPINAL-FLUID OF PATIENTS WITH ALZHEIMERS-DISEASE [J].
MOTTER, R ;
VIGOPELFREY, C ;
KHOLODENKO, D ;
BARBOUR, R ;
JOHNSONWOOD, K ;
GALASKO, D ;
CHANG, L ;
MILLER, B ;
CLARK, C ;
GREEN, R ;
OLSON, D ;
SOUTHWICK, P ;
WOLFERT, R ;
MUNROE, B ;
LIEBERBURG, I ;
SEUBERT, P ;
SCHENK, D .
ANNALS OF NEUROLOGY, 1995, 38 (04) :643-648
[9]   Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline [J].
Näslund, J ;
Haroutunian, V ;
Mohs, R ;
Davis, KL ;
Davies, P ;
Greengard, P ;
Buxbaum, JD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (12) :1571-1577
[10]   Immunization with amyloid-β attenuates Alzheimer disease-like pathology in the PDAPP mouse [J].
Schenk, D ;
Barbour, R ;
Dunn, W ;
Gordon, G ;
Grajeda, H ;
Guido, T ;
Hu, K ;
Huang, JP ;
Johnson-Wood, K ;
Khan, K ;
Kholodenko, D ;
Lee, M ;
Liao, ZM ;
Lieberburg, I ;
Motter, R ;
Mutter, L ;
Soriano, F ;
Shopp, G ;
Vasquez, N ;
Vandevert, C ;
Walker, S ;
Wogulis, M ;
Yednock, T ;
Games, D ;
Seubert, P .
NATURE, 1999, 400 (6740) :173-177